| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/11/2003 | US20030171697 Tester for automated identification of analytes in bodily fluids |
| 09/11/2003 | US20030171568 Diagnosing tumor or cancer in a mammal, and inflammatory diseases or disorders; inflammatory bowel disease, colon cancer; immunoassay, immunotherapy |
| 09/11/2003 | US20030171566 An isolated human nucleic acid encoding a nevoid basal cell carcinoma syndrome protein, antibodies, detecting tumor protein, therapeutic treatment of tumor, cancer; genetic engineering |
| 09/11/2003 | US20030171564 Novel argS |
| 09/11/2003 | US20030171559 A colony-stimulating factor hybrid molecules, computer analyzing the three dimensional structure protein, crystallization of the protein |
| 09/11/2003 | US20030171558 Mucin immobilized chromatography |
| 09/11/2003 | US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening |
| 09/11/2003 | US20030171550 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/11/2003 | US20030171548 Immunoreactive proteins where the percentage of immuno-reactive molecules as determined in a modified Lindmo-test is >81%; fermentation of culture of fluidized reactor; diagnosis of inflammatory and bone marrow displacing process |
| 09/11/2003 | US20030171545 Providing a leukotriene-B4 receptor-like polypeptide (LTRGW1) to stimulate the response of the leukotriene B4 receptor to leukotriene B4; antiinflammatory agents; asthma, chronic obstructive pulmonary disease; psoriasis |
| 09/11/2003 | US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides |
| 09/11/2003 | US20030171539 Synthetic oligopeptide heparin-neutralizing agents including basic amino acids and a N-heterocyclic end group; low turbidity; side effects reduction; in vitro diagnosis; calculate the blood clotting time; assaying clotting cascade |
| 09/11/2003 | US20030171537 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| 09/11/2003 | US20030171506 A mercapto group endcapping a polyethylene glycol for coating a biochip, detecting surface plasmon resonance; chemically adsorbed onto metal surface; reduce the adsorption of proteins on chips |
| 09/11/2003 | US20030171335 Antisense antiviral agent and method for treating ssRNA viral infection |
| 09/11/2003 | US20030171328 Non-invasive method for detecting target-RNA |
| 09/11/2003 | US20030171324 Reagents which bind to human DESC1-like serine protease gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to cancer, chronic obstructive pulmonary disease (COPD), |
| 09/11/2003 | US20030171319 Human chemokine beta-10 mutant polypeptides |
| 09/11/2003 | US20030171295 Drug screening assays, and diagnostic and therapeutic methods for the treatment of body weight disorders, such as obesity, anorexia and cachexia, utilizing the melanocortin 4-receptor (MC4-R) as the target for intervention |
| 09/11/2003 | US20030171293 Identification of an orphan G- protein coupled receptor MRGX2 (and variants thereof) as a receptor of neuropeptides such as but not limited to cortistatin, somatostatin, Bam 13-22, alpha -MSH, neuropeptide FF, dynorphin A and substance P, and the |
| 09/11/2003 | US20030171291 Novel treatment |
| 09/11/2003 | US20030171290 Methods to determine peptides presented on the surface of mammalian cells following addition to the cells of a protein. The present invention also relates to diagnostic tests based on the determination of such peptides or modified molecules |
| 09/11/2003 | US20030171286 Use and targeting of CD98 light-chain proteins in therapies for thyroid hormone disorders |
| 09/11/2003 | US20030171282 Systemic delivery of parathyroid hormone to a mammalian host is accomplished by inhalation through the mouth of a dispersion of an N-terminal fragment of PTH. It has been found that such respiratory delivery of the PTH fragment |
| 09/11/2003 | US20030171273 DNA of SEQ ID NO:1 is provided that encodes the transcription factor BP1, which is believed to be a repressor of the beta -globin gene. A host cell that is transformed with a vector that contains the DNA may be used to produce BP1. |
| 09/11/2003 | US20030171271 Therapeutic application in the treatment of conditions including cancer, macular degeneration and retinopathies. Also included are methods of treating a patient having a pathological condition characterized by an increase in |
| 09/11/2003 | US20030171270 Therapeutic compositions and methods relating to prolactin releasing peptide (PrRP) |
| 09/11/2003 | US20030171255 Modulating the phosphorylation of DARPP-32 in a serotonergic receptor intracellular signaling pathway. The invention provides methods and compositions for modulating the activities of DARPP-32, casein kinase 1 (CK1), |
| 09/11/2003 | US20030171253 Methods and compositions relating to modulation of A20 |
| 09/11/2003 | US20030170917 4-Hydroxyalkylphenethamines, used as an intermediate, hapten, or immunogen in the production of antibodies specific for ecstasy drugs; binding the antibody to the analyte and detecting the adduct formed; immunoassay |
| 09/11/2003 | US20030170916 Two elongated regions on a porified silicon substrate define two distinct, unconnected capillary columns each comprising a matrix and positioning a detector on said substrate adjacent one of the columns; miniaturized chromatography |
| 09/11/2003 | US20030170915 Multiplex analysis using membrane-bound sensitizers |
| 09/11/2003 | US20030170914 Replicable probe array |
| 09/11/2003 | US20030170913 Manufacture of a microsensor device and a method for evaluating the function of a liquid by the use thereof |
| 09/11/2003 | US20030170912 Method for the esr-spectroscopic detection of changes in the transport properties of albumin in an albumin-containing samples, esr-spectrometer for carrying out said method, and use of the method for diagnostic purposes and for controlling albumin-containing preparations |
| 09/11/2003 | US20030170911 Non-oligomerizing fluorescent proteins |
| 09/11/2003 | US20030170908 Method for making microsensor arrays for detecting analytes |
| 09/11/2003 | US20030170907 Immunoassay using lanthanide ions or their chelates as labels and dissociative fluorescence enhancement as a tool for detection where the enhancement solution comprises an aryl-carbonylmethylcarbonyl polyfluoroalkane; kinetics; stability |
| 09/11/2003 | US20030170905 A particle comprising a chromogen, a peroxide, an enhancer, a stabilizer, and a binder, the chromogen being selected to react with occult blood to produce a visible and immediate color change; kitty litter; veterinary medicine |
| 09/11/2003 | US20030170895 Methods of making hypermutable cells using PMSR homologs |
| 09/11/2003 | US20030170890 Produced by conversion of healthy myocardial cell by stimulation with hormones, hormone analogs and/or cytokines; used for detecting and identifying substances acting on the heart |
| 09/11/2003 | US20030170889 In vivo assay for anti angiogenic compounds |
| 09/11/2003 | US20030170882 Method of manufacturing a self-sealing chamber |
| 09/11/2003 | US20030170881 Apparatus and methods for analyte measurement and immuno assay |
| 09/11/2003 | US20030170880 Microchip device for chemotaxis observation |
| 09/11/2003 | US20030170864 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/11/2003 | US20030170860 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
| 09/11/2003 | US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 09/11/2003 | US20030170858 Gyrase inhibitors and uses thereof |
| 09/11/2003 | US20030170849 Tyrosylprotein sulfotransferases |
| 09/11/2003 | US20030170842 Crystal proteins comprising proline substitutions; vapor diffusion; nuclear magnetic resonance; high resolution |
| 09/11/2003 | US20030170840 Genomic mammary amyloid a sequence |
| 09/11/2003 | US20030170839 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/11/2003 | US20030170838 Novel polynucleotides and polypeptides encoded thereby |
| 09/11/2003 | US20030170827 Purified mammalian cytokines; related reagents and methods |
| 09/11/2003 | US20030170826 Fusion proteins include cell penetrating domain linked to transmembrane domain |
| 09/11/2003 | US20030170816 Method for in vitro propagation of the agent responsible for transmissible spongiform encephalopathies |
| 09/11/2003 | US20030170812 Interleukin-1beta converting enzyme like cysteine protease |
| 09/11/2003 | US20030170808 Polypeptide encoded by polynucleotide of given sequence; use in diagnosis and treatment of various diseases |
| 09/11/2003 | US20030170792 MAGE-3 peptides presented by HLA class ll molecules |
| 09/11/2003 | US20030170790 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors |
| 09/11/2003 | US20030170789 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors |
| 09/11/2003 | US20030170788 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/11/2003 | US20030170785 CDNA encoding the human alpha2 delta4 calcium channel subunit |
| 09/11/2003 | US20030170782 Proteins |
| 09/11/2003 | US20030170777 An isolated nucleic acid molecule that encodes the amino acid sequence, cell culturing, binding to antibody, non-human transgenic animal, antithrombotic drugs, treating cardiovascular diseases, genetic engineering |
| 09/11/2003 | US20030170772 Complex of tetrazole dye and phenazine; detection, measurement |
| 09/11/2003 | US20030170771 Compounds for generating chemiluminescence with a peroxidase |
| 09/11/2003 | US20030170768 Dry analyzing; colorimetric analysis; measuring concentration of triglycerides; storage stability |
| 09/11/2003 | US20030170765 Biological Conjugation with an enzyme donor, enzyme acceptor, and a substrate, competetive binding, detecting kinases or phosphatases |
| 09/11/2003 | US20030170764 Rapid, immunochemical process for measuring thiopurine methyltransferase |
| 09/11/2003 | US20030170763 Protein antiallergens |
| 09/11/2003 | US20030170762 Compounds for generating chemiluminescence with a peroxidase |
| 09/11/2003 | US20030170761 Neutralizing epitopes; induce immunology response |
| 09/11/2003 | US20030170759 Detection, monitoring ovarian tumors; using enzyme inhibitor |
| 09/11/2003 | US20030170758 Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies |
| 09/11/2003 | US20030170757 Diagnosis of cancer tissue; monoclonal antibodies |
| 09/11/2003 | US20030170755 Tumor-associated antigen RHAMM |
| 09/11/2003 | US20030170754 Anticancer agents; diagnosis of prostate cancer |
| 09/11/2003 | US20030170753 Artificial antibody polypeptides |
| 09/11/2003 | US20030170752 Prevention of breast cancer |
| 09/11/2003 | US20030170751 Immunohistochemical assay for ras activity |
| 09/11/2003 | US20030170750 Urogenital carcinoma tlp complex peptides and antibodies thereof |
| 09/11/2003 | US20030170749 Detection using antibodies; parasiticides; veterinary medicine |
| 09/11/2003 | US20030170748 Compositions and methods for increasing amino acid absorption in mammals |
| 09/11/2003 | US20030170747 Peripheral marker of blood brain barrier permeability |
| 09/11/2003 | US20030170746 Method for screening an agent for ability to inhibit heparanase activity |
| 09/11/2003 | US20030170745 Antiinflammatory agents; atherosclerosis; Alzheimer's disease; antihistamines; antiarthritic agents; detecting protein in fluid sample |
| 09/11/2003 | US20030170744 Multiplexed analysis of cellular responses using endogenous reporter genes |
| 09/11/2003 | US20030170741 Methods for identifying compounds for regulating muscle mass or function using dopamine receptors |
| 09/11/2003 | US20030170740 Exposure to estrogen; detection gene expression; calibration |
| 09/11/2003 | US20030170739 Polynucleotide sequence using markers |
| 09/11/2003 | US20030170738 Compounds that modulate processes associated with IgE production and methods and kits for identifying and using the same |
| 09/11/2003 | US20030170735 Introducing suspension of mammalian cells to combinatorial peptide library comprising multiple beads with attached synthetic compounds, incubating, identifying bead with growing cells, isolating, determining structure of compound |
| 09/11/2003 | US20030170734 Complexing sample; then splitting; drug development |
| 09/11/2003 | US20030170733 Plates; three-dimensional layouts; wells; fluid flow; screening libraries |
| 09/11/2003 | US20030170731 Detection Helicobacter infections; immunoassay; gastrointestinal disorders |
| 09/11/2003 | US20030170730 Testing for drug desistance of cancer drugs |
| 09/11/2003 | US20030170729 Process for the measurement of the potency of glatiramer acetate |
| 09/11/2003 | US20030170728 Synthetic opiods; analgesics; induction of polyclonal antibodies |